Cargando…
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic
OBJECTIVE: Most reports on the declining incidence of myocardial infarction (MI) during the COVID-19 have either been anecdotal, survey results or geographically limited to areas with lockdowns. We examined the incidence of MI during the COVID-19 pandemic in Sweden, which has remained an open societ...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677488/ https://www.ncbi.nlm.nih.gov/pubmed/33023905 http://dx.doi.org/10.1136/heartjnl-2020-317685 |
_version_ | 1783611985127014400 |
---|---|
author | Mohammad, Moman A Koul, Sasha Olivecrona, Göran K Gӧtberg, Matthias Tydén, Patrik Rydberg, Erik Scherstén, Fredrik Alfredsson, Joakim Vasko, Peter Omerovic, Elmir Angerås, Oskar Fröbert, Ole Calais, Fredrik Völz, Sebastian Ulvenstam, Anders Venetsanos, Dimitrios Yndigegn, Troels Oldgren, Jonas Sarno, Giovanna Grimfjärd, Per Persson, Jonas Witt, Nils Ostenfeld, Ellen Lindahl, Bertil James, Stefan K Erlinge, David |
author_facet | Mohammad, Moman A Koul, Sasha Olivecrona, Göran K Gӧtberg, Matthias Tydén, Patrik Rydberg, Erik Scherstén, Fredrik Alfredsson, Joakim Vasko, Peter Omerovic, Elmir Angerås, Oskar Fröbert, Ole Calais, Fredrik Völz, Sebastian Ulvenstam, Anders Venetsanos, Dimitrios Yndigegn, Troels Oldgren, Jonas Sarno, Giovanna Grimfjärd, Per Persson, Jonas Witt, Nils Ostenfeld, Ellen Lindahl, Bertil James, Stefan K Erlinge, David |
author_sort | Mohammad, Moman A |
collection | PubMed |
description | OBJECTIVE: Most reports on the declining incidence of myocardial infarction (MI) during the COVID-19 have either been anecdotal, survey results or geographically limited to areas with lockdowns. We examined the incidence of MI during the COVID-19 pandemic in Sweden, which has remained an open society with a different public health approach fighting COVID-19. METHODS: We assessed the incidence rate (IR) as well as the incidence rate ratios (IRRs) of all MI referred for coronary angiography in Sweden using the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR), during the COVID-19 pandemic in Sweden (1 March 2020–7 May 2020) in relation to the same days 2015–2019. RESULTS: A total of 2443 MIs were referred for coronary angiography during the COVID-19 pandemic resulting in an IR 36 MIs/day (204 MIs/100 000 per year) compared with 15 213 MIs during the reference period with an IR of 45 MIs/day (254 MIs/100 000 per year) resulting in IRR of 0.80, 95% CI (0.74 to 0.86), p<0.001. Results were consistent in all investigated patient subgroups, indicating no change in patient category seeking cardiac care. Kaplan-Meier event rates for 7-day case fatality were 439 (2.3%) compared with 37 (2.9%) (HR: 0.81, 95% CI (0.58 to 1.13), p=0.21). Time to percutaneous coronary intervention (PCI) was shorter during the pandemic and PCI was equally performed, indicating no change in quality of care during the pandemic. CONCLUSION: The COVID-19 pandemic has significantly reduced the incidence of MI referred for invasive treatment strategy. No differences in overall short-term case fatality or quality of care indicators were observed. |
format | Online Article Text |
id | pubmed-7677488 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-76774882020-11-30 Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic Mohammad, Moman A Koul, Sasha Olivecrona, Göran K Gӧtberg, Matthias Tydén, Patrik Rydberg, Erik Scherstén, Fredrik Alfredsson, Joakim Vasko, Peter Omerovic, Elmir Angerås, Oskar Fröbert, Ole Calais, Fredrik Völz, Sebastian Ulvenstam, Anders Venetsanos, Dimitrios Yndigegn, Troels Oldgren, Jonas Sarno, Giovanna Grimfjärd, Per Persson, Jonas Witt, Nils Ostenfeld, Ellen Lindahl, Bertil James, Stefan K Erlinge, David Heart Coronary Artery Disease OBJECTIVE: Most reports on the declining incidence of myocardial infarction (MI) during the COVID-19 have either been anecdotal, survey results or geographically limited to areas with lockdowns. We examined the incidence of MI during the COVID-19 pandemic in Sweden, which has remained an open society with a different public health approach fighting COVID-19. METHODS: We assessed the incidence rate (IR) as well as the incidence rate ratios (IRRs) of all MI referred for coronary angiography in Sweden using the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR), during the COVID-19 pandemic in Sweden (1 March 2020–7 May 2020) in relation to the same days 2015–2019. RESULTS: A total of 2443 MIs were referred for coronary angiography during the COVID-19 pandemic resulting in an IR 36 MIs/day (204 MIs/100 000 per year) compared with 15 213 MIs during the reference period with an IR of 45 MIs/day (254 MIs/100 000 per year) resulting in IRR of 0.80, 95% CI (0.74 to 0.86), p<0.001. Results were consistent in all investigated patient subgroups, indicating no change in patient category seeking cardiac care. Kaplan-Meier event rates for 7-day case fatality were 439 (2.3%) compared with 37 (2.9%) (HR: 0.81, 95% CI (0.58 to 1.13), p=0.21). Time to percutaneous coronary intervention (PCI) was shorter during the pandemic and PCI was equally performed, indicating no change in quality of care during the pandemic. CONCLUSION: The COVID-19 pandemic has significantly reduced the incidence of MI referred for invasive treatment strategy. No differences in overall short-term case fatality or quality of care indicators were observed. BMJ Publishing Group 2020-12 2020-10-06 /pmc/articles/PMC7677488/ /pubmed/33023905 http://dx.doi.org/10.1136/heartjnl-2020-317685 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Coronary Artery Disease Mohammad, Moman A Koul, Sasha Olivecrona, Göran K Gӧtberg, Matthias Tydén, Patrik Rydberg, Erik Scherstén, Fredrik Alfredsson, Joakim Vasko, Peter Omerovic, Elmir Angerås, Oskar Fröbert, Ole Calais, Fredrik Völz, Sebastian Ulvenstam, Anders Venetsanos, Dimitrios Yndigegn, Troels Oldgren, Jonas Sarno, Giovanna Grimfjärd, Per Persson, Jonas Witt, Nils Ostenfeld, Ellen Lindahl, Bertil James, Stefan K Erlinge, David Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic |
title | Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic |
title_full | Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic |
title_fullStr | Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic |
title_full_unstemmed | Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic |
title_short | Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic |
title_sort | incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during covid-19 pandemic |
topic | Coronary Artery Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677488/ https://www.ncbi.nlm.nih.gov/pubmed/33023905 http://dx.doi.org/10.1136/heartjnl-2020-317685 |
work_keys_str_mv | AT mohammadmomana incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT koulsasha incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT olivecronagorank incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT götbergmatthias incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT tydenpatrik incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT rydbergerik incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT scherstenfredrik incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT alfredssonjoakim incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT vaskopeter incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT omerovicelmir incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT angerasoskar incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT frobertole incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT calaisfredrik incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT volzsebastian incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT ulvenstamanders incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT venetsanosdimitrios incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT yndigegntroels incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT oldgrenjonas incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT sarnogiovanna incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT grimfjardper incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT perssonjonas incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT wittnils incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT ostenfeldellen incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT lindahlbertil incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT jamesstefank incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic AT erlingedavid incidenceandoutcomeofmyocardialinfarctiontreatedwithpercutaneouscoronaryinterventionduringcovid19pandemic |